{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:54:46Z","timestamp":1783979686886,"version":"3.55.0"},"reference-count":55,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:p>Children with Duchenne muscular dystrophy (DMD) are shorter than their healthy peers. The introduction of corticosteroid (CS) has beneficial effects on muscle function but slows growth further and is associated with pubertal delay. In contrast to CS usage in most children and adolescents, weaning glucocorticoid is not a key objective of management in DMD. As the outlook for these young people improves, one of the main challenges is to reduce or offset the detrimental effects of CS on growth and development. This is a review of the aetiology and prevalence of short stature and delayed puberty in DMD, a summary of the treatments available and suggestions for areas of further research.<\/jats:p>","DOI":"10.1136\/archdischild-2015-308654","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T03:00:18Z","timestamp":1435978818000},"page":"101-106","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":63,"title":["Short stature and pubertal delay in Duchenne muscular dystrophy"],"prefix":"10.1136","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-5174","authenticated-orcid":false,"given":"Claire L","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Guglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Bushby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Cheetham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,7,3]]},"reference":[{"key":"key-10.1136\/archdischild-2015-308654-1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann Neurol"},{"key":"key-10.1136\/archdischild-2015-308654-2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/archdischild-2015-308654-3","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1177\/0883073810371004","article-title":"Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management","volume":"25","author":"Moxley","year":"2010","journal-title":"J Child Neurol"},{"key":"key-10.1136\/archdischild-2015-308654-4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.23808","article-title":"The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures","volume":"48","author":"Henricson","year":"2013","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/archdischild-2015-308654-5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.nmd.2007.02.005","article-title":"Strength and corticosteroid responsiveness of mdx mice is unchanged by RAG2 gene knockout","volume":"17","author":"Golumbek","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"key-10.1136\/archdischild-2015-308654-6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/jnnp-2012-303902","article-title":"Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy","volume":"84","author":"Ricotti","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"(1)","key":"key-10.1136\/archdischild-2015-308654-7","first-page":"CD003725","article-title":"Glucocorticoid corticosteroids for Duchenne muscular dystrophy","author":"Manzur","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.1136\/archdischild-2015-308654-8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jacc.2012.12.011","article-title":"Steroid therapy effectively delays Duchenne's cardiomyopathy","volume":"61","author":"Dec","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key-10.1136\/archdischild-2015-308654-9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.nmd.2008.03.002","article-title":"Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy","volume":"18","author":"Markham","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"key-10.1136\/archdischild-2015-308654-10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/01.phm.0000184156.98671.d0","article-title":"Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect","volume":"84","author":"Balaban","year":"2005","journal-title":"Am J Phys Med Rehabil"},{"key":"key-10.1136\/archdischild-2015-308654-11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nmd.2006.01.010","article-title":"Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade","volume":"16","author":"Biggar","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"key-10.1136\/archdischild-2015-308654-12","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2106\/JBJS.L.01577","article-title":"Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up","volume":"95","author":"Lebel","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"key-10.1136\/archdischild-2015-308654-13","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.nmd.2012.07.009","article-title":"Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure","volume":"22","author":"Rutter","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"key-10.1136\/archdischild-2015-308654-14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.nmd.2011.02.006","article-title":"Endocrine aspects of Duchenne muscular dystrophy","volume":"21","author":"Bianchi","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"key-10.1136\/archdischild-2015-308654-15","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/1097-4598(200009)23:9<1344::AID-MUS4>3.0.CO;2-F","article-title":"A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy","volume":"23","author":"Bonifati","year":"2000","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/archdischild-2015-308654-16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/jama.282.7.671","article-title":"Glucocorticoid-induced adrenal insufficiency","volume":"282","author":"Krasner","year":"1999","journal-title":"JAMA"},{"key":"key-10.1136\/archdischild-2015-308654-17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/000992280304200408","article-title":"Vertebral fractures in boys with Duchenne muscular dystrophy","volume":"42","author":"Bothwell","year":"2003","journal-title":"Clin Pediatr (Phila)"},{"key":"key-10.1136\/archdischild-2015-308654-18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.nmd.2004.05.001","article-title":"Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols","volume":"14","author":"Biggar","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"key-10.1136\/archdischild-2015-308654-19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/BF00442472","article-title":"Short stature: a common feature in Duchenne muscular dystrophy","volume":"147","author":"Eiholzer","year":"1988","journal-title":"Eur J Pediatr"},{"key":"key-10.1136\/archdischild-2015-308654-20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/adc.72.5.437","article-title":"Duchenne muscular dystrophy presenting with failure to thrive","volume":"72","author":"Rapisarda","year":"1995","journal-title":"Arch Dis Child"},{"key":"key-10.1136\/archdischild-2015-308654-21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000111816","article-title":"Novel SHOX gene mutation in a short boy with Becker muscular dystrophy: double trouble in two adjacent genes","volume":"69","author":"Messina","year":"2008","journal-title":"Horm Res"},{"key":"key-10.1136\/archdischild-2015-308654-22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1651-2227.1999.tb01270.x","article-title":"Short stature in Duchenne muscular dystrophy: a study of 34 patients","volume":"88","author":"Nagel","year":"1999","journal-title":"Acta Paediatr"},{"key":"key-10.1136\/archdischild-2015-308654-23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejpn.2013.08.008","article-title":"Growth and psychomotor development of patients with Duchenne muscular dystrophy","volume":"18","author":"Sarrazin","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"key-10.1136\/archdischild-2015-308654-24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/mus.23304","article-title":"Corticosteroids and Duchenne muscular dystrophy: does earlier treatment really matter?","volume":"45","author":"McDonald","year":"2012","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/archdischild-2015-308654-25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/archdischild-2015-308654-26","unstructured":"Bushby K , Griggs R . FOR-DMD. Finding the Optimum Regimen for Duchenne Muscular Dystrophy. An NIH Funded Trial of Steroids. 2011. Clinical Trial.Gov ref NCT01603407."},{"key":"key-10.1136\/archdischild-2015-308654-27","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.0b013e318227b164","article-title":"Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy","volume":"77","author":"Escolar","year":"2011","journal-title":"Neurology"},{"key":"key-10.1136\/archdischild-2015-308654-28","first-page":"248","article-title":"Revision and update of Tanner-Whitehouse clinical longitudinal charts for height and weight","volume":"156","author":"Tanner","year":"1997","journal-title":"Eur J Pediatr"},{"key":"key-10.1136\/archdischild-2015-308654-29","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1210\/jcem.83.8.5036","article-title":"Treatment of glucocorticoid-induced growth suppression with growth hormone. National Cooperative Growth Study","volume":"83","author":"Allen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2015-308654-30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1011455826842","article-title":"Growth hormone (GH) secretion in primary adrenal insufficiency: effects of cortisol withdrawal and patterned replacement on GH pulsatility and circadian rhythmicity","volume":"3","author":"Barkan","year":"2000","journal-title":"Pituitary"},{"key":"key-10.1136\/archdischild-2015-308654-31","first-page":"738","article-title":"Prediction equations based on arm measurements may overestimate standingheight in Duchenne Muscular Dystrophy (DMD) patients on glucocorticoid (GC) therapy","volume":"13","author":"Wong","year":"2013","journal-title":"NM Disorders"},{"key":"key-10.1136\/archdischild-2015-308654-32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1469-8749.2004.tb00508.x","article-title":"Height prediction from ulna length","volume":"46","author":"Gauld","year":"2004","journal-title":"Dev Med Child Neurol"},{"key":"key-10.1136\/archdischild-2015-308654-33","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1136\/adc.63.10.1256","article-title":"A new chart for weight control in Duchenne muscular dystrophy","volume":"63","author":"Griffiths","year":"1988","journal-title":"Arch Dis Child"},{"key":"key-10.1136\/archdischild-2015-308654-34","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1517\/14656566.6.8.1319","article-title":"New facets of androgen replacement therapy during childhood and adolescence","volume":"6","author":"Rogol","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.1136\/archdischild-2015-308654-35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/adc.66.2.197","article-title":"Depot testosterone in boys with anorchia or gonadotrophin deficiency: effect on growth rate and adult height","volume":"66","author":"Moorthy","year":"1991","journal-title":"Arch Dis Child"},{"key":"key-10.1136\/archdischild-2015-308654-36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMcp1109290","article-title":"Clinical practice. Delayed puberty","volume":"366","author":"Palmert","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.1136\/archdischild-2015-308654-37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/adc.87.2.93","article-title":"The impact of corticosteroids on growth and bone health","volume":"87","author":"Mushtaq","year":"2002","journal-title":"Arch Dis Child"},{"key":"key-10.1136\/archdischild-2015-308654-38","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJM200003233421204","article-title":"Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis","volume":"342","author":"Lai","year":"2000","journal-title":"N Engl J Med"},{"key":"key-10.1136\/archdischild-2015-308654-39","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0091-6749(94)70043-5","article-title":"A meta-analysis of the effect of oral and inhaled corticosteroids on growth","volume":"93","author":"Allen","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.1136\/archdischild-2015-308654-40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5114\/aoms.2010.13501","article-title":"Growth retardation and delayed puberty in children and adolescents with juvenile idiopathic arthritis","volume":"6","author":"Umlawska","year":"2010","journal-title":"Arch Med Sci"},{"key":"key-10.1136\/archdischild-2015-308654-41","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/mus.880131212","article-title":"Randomized, double-blind trial of mazindol in Duchenne dystrophy","volume":"13","author":"Griggs","year":"1990","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/archdischild-2015-308654-42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/BF02337165","article-title":"Growth hormone evaluation in Duchenne muscular dystrophy","volume":"9","author":"Merlini","year":"1988","journal-title":"Ital J Neurol Sci"},{"key":"key-10.1136\/archdischild-2015-308654-43","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1210\/jc.2006-1610","article-title":"Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity","volume":"92","author":"Chernausek","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2015-308654-44","first-page":"E331","article-title":"Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism","volume":"267","author":"Fryburg","year":"1994","journal-title":"Am J Physiol"},{"key":"key-10.1136\/archdischild-2015-308654-45","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tem.2013.03.004","article-title":"The therapeutic potential of IGF-I in skeletal muscle repair","volume":"24","author":"Song","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2015-308654-46","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.nmd.2013.06.576","article-title":"P.11.15 Recombinant human insulin-like growth factor-I (IGF-I) therapy in Duchenne Muscular Dystrophy (DMD): A 6-month prospective randomized controlled trial","volume":"23","author":"Rutter","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"key-10.1136\/archdischild-2015-308654-47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000315902","article-title":"Effect of testosterone therapy for delayed growth and puberty in boys with inflammatory bowel disease","volume":"75","author":"Mason","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"key-10.1136\/archdischild-2015-308654-48","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/archpedi.1984.02140420054017","article-title":"Short stature and pubertal delay in male adolescents with cystic fibrosis. Androgen treatment","volume":"138","author":"Landon","year":"1984","journal-title":"Am J Dis Child"},{"key":"key-10.1136\/archdischild-2015-308654-49","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1212\/WNL.56.8.1075","article-title":"A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy","volume":"56","author":"Fenichel","year":"2001","journal-title":"Neurology"},{"key":"key-10.1136\/archdischild-2015-308654-50","first-page":"332","article-title":"Effect of testosterone on metabolic rate and body composition in normal men and men with muscular dystrophy","volume":"74","author":"Welle","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2015-308654-51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1515\/JPEM.2005.18.2.171","article-title":"Constitutional delay of growth and puberty: from presentation to final height","volume":"18","author":"Poyrazoglu","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2015-308654-52","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00431-007-0576-y","article-title":"Adult height in children with short stature and idiopathic delayed puberty after different management","volume":"167","author":"Zucchini","year":"2008","journal-title":"Eur J Pediatr"},{"key":"key-10.1136\/archdischild-2015-308654-53","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mpo.2950220407","article-title":"Pubertal growth in response to testosterone replacement therapy for radiation-induced Leydig cell failure","volume":"22","author":"Didi","year":"1994","journal-title":"Med Pediatr Oncol"},{"key":"key-10.1136\/archdischild-2015-308654-54","first-page":"4358","article-title":"Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism","volume":"81","author":"Katznelson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.1136\/archdischild-2015-308654-55","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/adc.51.3.170","article-title":"Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty","volume":"51","author":"Tanner","year":"1976","journal-title":"Arch Dis Child"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2015-308654","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T10:57:27Z","timestamp":1601117847000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2015-308654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,3]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,14]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1136\/archdischild-2015-308654"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2015-308654","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,3]]}}}